|
Re: Generic Hercpetin coming soon to your cancer center?
I don't quite understand this. It appears to me that before a bio-similar form of Herceptin could be allowed by FDA there would have to be clinical trials to prove the saftey and effectiveness of the new generic form of the medicine. Fighting Her 2+ breast cancer with anything but the best agents is risking too much IMHO.---bird
__________________
Male Breast Cancer, DX 5/15/09, IDC, STAGE 1, 1.7 cm, HER2+++, ER+(95%)/PR+(75%), Ki67 40%, grade 3, 0/5 nodes, TX: mastectomy, TCH finished 7/19/10, radiation 6 wks., Tamoxifen on going, bisphosphonate 24 mos.
|
Threaded Mode